Breaking News

NYC Newswire is the only newswire service dedicated to the New York City market. Your news is distributed and shared on NYC hyperlocal websites, reaching your exact target audience.

Targeted Search

Featured News

All News

Kota the Friend & TIDAL Partner for Flight Night NYC

Brooklyn-born independent hip-hop artist Kota the Friend is bringing Flight Night back to New York City for a two-day music and arts experience December 10–11, 2026, with TIDAL as presenting partner. Organized through Kota's FLTBYS brand, the event begins December 10 with Local Art Dealer IRL, an invitation-based gathering for independent musicians, artists, managers and creative entrepreneurs focused on ownership and direct-to-fan opportunities. On December 11, Kota will headline a concert at SOB's in Manhattan alongside Statik Selektah, Neptune XXI, Iman Nunez and Life of Thom. Flight Night has previously hosted events in cities across the United States and Europe. Concert tickets are available through FlightNight.com, while interested artists can apply to attend the gathering.

Hyatt Plans 1,800-Room StandardX Hotel in Times Square

Hyatt Hotels Corporation and Extell Development Company have announced plans for The StandardX Times Square, an approximately 1,800-room hotel at 255 West 45th Street in Manhattan's Theater District. Expected to open in the second half of 2028, the property will mark the first North American location for The StandardX brand. The development is planned to include an enclosed free-fall thrill ride, an observation deck more than 1,000 feet above Manhattan, a rooftop pool, restaurants, bars and nightlife venues. Developed by Extell, the project will combine hotel accommodations with entertainment attractions accessible to visitors and New Yorkers. The companies say additional details about the property's design, dining concepts and creative collaborations will be announced later.

NY Health Insurance Open Enrollment Starts Nov. 1

The New York State Department of Health has announced that open enrollment for 2027 Qualified Health Plans begins November 1, 2026, and continues through January 31, 2027. Residents seeking coverage beginning January 1 are encouraged to enroll by December 15. More than 800,000 New Yorkers are up for renewal statewide across NY State of Health programs. The Marketplace offers Qualified Health Plans, Medicaid, Child Health Plus and the Essential Plan, with free assistance available through more than 9,000 enrollment assistors. Officials are also encouraging residents affected by federal eligibility changes to review their coverage options. Oscar Health will no longer participate in the Marketplace for 2027, requiring approximately 4,800 affected consumers to select another plan.

Cleary Gottlieb Names NY Based Mark Pflug M&A Partner

Cleary Gottlieb Steen & Hamilton has announced that Mark Pflug has joined the international law firm as a New York-based partner in its Americas M&A and Private Equity Transactions groups. Pflug brings approximately two decades of experience advising private equity sponsors and public and private companies on acquisitions, investments, recapitalizations, joint ventures and other complex transactions. His practice spans healthcare, life sciences, real estate services, industrial businesses, technology, media and telecommunications, including cross-border deals in Europe and Asia. His appointment follows several other senior additions to Cleary's M&A practice during 2026, including Niqui Kohli, Emmanuel Enrici and Matthew Schwartz. The firm says the expansion strengthens its capabilities in private equity and corporate transactions.

NYU Study Finds New Drug Reduces Cancer Death Risk

An international phase 3 clinical trial led by researchers at NYU Langone Health's Perlmutter Cancer Center found that sacituzumab tirumotecan, a targeted cancer drug, improved outcomes for patients with previously treated advanced or recurrent endometrial cancer. Among 776 women, those assigned to the drug had a 41% lower relative risk of disease progression and a 32% lower relative risk of death compared with patients receiving standard chemotherapy. Tumor responses occurred in 35.1% of patients receiving sacituzumab tirumotecan, compared with 17.3% in the chemotherapy group. The findings, scheduled for presentation October 26 and publication in The Lancet, could inform future treatment guidelines, although regulatory status and longer-term outcomes require clarification.

NYC Launches SNAP and Medicaid Work Rules Website

New York City has launched an online resource to help residents understand federal SNAP and Medicaid work requirements, identify potential exemptions and maintain access to food and healthcare assistance. Available at NYC.gov/workrules, the webpage guides users through questions about age, employment, education and other circumstances to explain which requirements may apply. It also connects residents with benefits hotlines, food assistance, job opportunities, approved volunteer activities and NYC Care. Expanded SNAP work requirements took effect March 1, 2026, while additional Medicaid requirements are scheduled to begin January 1, 2027. City officials say their outreach efforts have helped more than 220,000 New Yorkers at risk of losing SNAP benefits.